| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/27/2006 | WO2004026453A3 Microcapsules and methods of use |
| 04/27/2006 | WO2003065993A8 Primary rat hepatocyte toxicity modeling |
| 04/27/2006 | US20060089674 Method of treating biological materials with translating electrical fields and electrode polarity reversal |
| 04/27/2006 | US20060089620 Medication infusion device using negatively biased ambient pressure medication chamber |
| 04/27/2006 | US20060089619 Implantable pump with integrated refill detection |
| 04/27/2006 | US20060089385 Pharmaceutical compositions |
| 04/27/2006 | US20060089326 Immunostimulatory nucleic acid molecules |
| 04/27/2006 | US20060088923 Enzyme granulate production method and resulting enzyme granulates |
| 04/27/2006 | US20060088599 Amino functionalized ORMOSIL nanoparticles as delivery vehicles |
| 04/27/2006 | US20060088598 Intravenous composition, process for producing the same and preparation thereof |
| 04/27/2006 | US20060088597 Agent delivery system |
| 04/27/2006 | US20060088596 Solubilizing a drug for use in a coating |
| 04/27/2006 | US20060088595 Dispersant for sustained release preparations |
| 04/27/2006 | US20060088594 Highly compressible controlled delivery compositions of metformin |
| 04/27/2006 | US20060088593 Dosage forms having a microreliefed surface and methods and apparatus for their production |
| 04/27/2006 | US20060088592 Oral formulation for delivery of poorly absorbed drugs |
| 04/27/2006 | US20060088591 Tablets from a poorly compressible substance |
| 04/27/2006 | US20060088590 Non-blooming gelatin and non-gelatin formulations |
| 04/27/2006 | US20060088589 Reinforced absorbable multilayered hemostatic wound dressing |
| 04/27/2006 | US20060088588 Medication administering device and system |
| 04/27/2006 | US20060088587 Dosage forms having a microreliefed surface and methods and apparatus for their production |
| 04/27/2006 | US20060088586 Dosage forms having a microreliefed surface and methods and apparatus for their production |
| 04/27/2006 | US20060088585 Dosage forms having a microreliefed surface and methods and apparatus for their production |
| 04/27/2006 | US20060088584 Storage stability; freeze drying; mixture containing phospholipids and monosaccharides; regenerated as aqueous solution;administering by injection |
| 04/27/2006 | US20060088583 Artificial oxygen carrier containing preventive agents of metHb formation |
| 04/27/2006 | US20060088582 Phosphatidyl oligo glycerins and structural analogs |
| 04/27/2006 | US20060088581 Device for delivery of therapeutic agent |
| 04/27/2006 | US20060088580 Hormone-containing transdermal therapeutic system with an active substance reservoir based on vinylacetate-vinylpyrrolidone copolymer with improved cohesion |
| 04/27/2006 | US20060088579 Transdermal drug delivery systems |
| 04/27/2006 | US20060088578 comprising an isotropic layer of cross-linked biopolymeric fibers such as collagen or polysaccharides, wherein fibers are 10 to 1,000 cm in length and membrane is permeable to molecules having molecular weights of 50 to 100,000 daltons; for repairing a damaged tissue |
| 04/27/2006 | US20060088577 Process for manufacturing fibrin membranes and fibrin membranes obtained according to this process |
| 04/27/2006 | US20060088561 solidifying agent consists of long chain fatty alcohol; carrier is semi-solid at rest and liquefies upon application of shear forces |
| 04/27/2006 | US20060088558 Vitamin E TPGS fluid concentrate comprising a low percentage of water |
| 04/27/2006 | US20060088556 Topical formulation and use of buspirone |
| 04/27/2006 | US20060088536 Therapeutic drug using antibody-presenting hollow protein nanoparticles and hollow protein nanoparticles |
| 04/27/2006 | US20060088530 Administering lyposomes of photosensitive receptors or ligands targeted to specific tissues, exposure to light causing destruction of bound tissues; treatment of eye neovascular disease due to macular degeneration, diabetes |
| 04/27/2006 | US20060088524 Tissue factor compositions and methods |
| 04/27/2006 | US20060088518 Stable thrombin composition |
| 04/27/2006 | US20060088514 Formulation comprising a bacterial strain |
| 04/27/2006 | US20060088510 Promotes the growth and differentiation of cells; attached therapeutic agents can be used to promote this process and the gel along with the growing cells can be implanted at a site in vivo where tissue repair is needed; membranes can be used for culturing cells in vitro; delivering drugs in vitro |
| 04/27/2006 | US20060088504 Compositions and methods for effecting the levels of high density lipoprotein (HDL) cholesterol and apolipoprotein Al, very low density lipoprotein (VLDL) cholesterol and low density lipoprotein (LDL) cholesterol |
| 04/27/2006 | US20060088498 Anti-microbial composition using in-situ generation of an oxidizing agent |
| 04/27/2006 | US20060088481 Topical oral dosage forms containing bismuth compounds |
| 04/27/2006 | US20060088480 Oral composition for stabilization, (re)calcification and (re)mineralization of tooth enamel and dentine |
| 04/27/2006 | US20060088479 Particle formulation and its preparation |
| 04/27/2006 | DE4227779B4 Zur Anwendung am Körper, in der Pharmazie oder in der Kosmetik bestimmte Dreiphasen-Lotion For use on the body, in pharmacy or in cosmetology certain three-phase lotion |
| 04/27/2006 | DE4215450B4 Topische Pharmazeutische Mittel und Verfahren zu ihrer Herstellung A topical pharmaceutical means and methods for their preparation |
| 04/27/2006 | DE19640062B4 Orale Zubereitung, enthaltend in einer in wässrigem Medium quellbaren Matrix wenigstens einen pharmazeutischen Wirkstoff The oral composition containing a swellable in aqueous medium matrix least one active pharmaceutical ingredient |
| 04/27/2006 | DE10235475B4 Arzneimittel mit einer Benzimidazolverbindung im Gemisch mit mikrokristalliner Cellulose und Verfahren zu deren Herstellung Drugs with a benzimidazole compound in mixture with microcrystalline cellulose and process for their preparation |
| 04/27/2006 | DE102004038285A1 Use of ethereal oils containing a polymer matrix for the production of drug delivery systems for the transdermal and/or by inhalation application of ethereal oils in aroma therapy |
| 04/27/2006 | DE102004011663B4 Erythropoietin-Flüssigformulierung Erythropoietin liquid formulation |
| 04/27/2006 | DE10164687B4 Crystalline citalopram base and salts with high purity useful for treatment of depression |
| 04/27/2006 | DE10010759B4 Verfahren zur Herstellung von Formkörpern A process for the production of molded articles |
| 04/27/2006 | CA2584560A1 Type ii cubic liquid crystal composition |
| 04/27/2006 | CA2584505A1 Purified phospholipid-non-steroidal anti-inflammatory drug associated compositions and methods for preparing and using same |
| 04/27/2006 | CA2584401A1 Food supplement containing fish oil |
| 04/27/2006 | CA2584276A1 Anti-snoring composition |
| 04/27/2006 | CA2584184A1 Methods and compositions for reducing toxicity of a pharmaceutical compound |
| 04/27/2006 | CA2584124A1 Flavonoid composition for treating oral diseases |
| 04/27/2006 | CA2583367A1 Cytotoxic formulation for combination therapy |
| 04/27/2006 | CA2583332A1 Liposomal composition comprising an active ingredient for relaxing smooth muscle production and therapeutically use of said composition |
| 04/26/2006 | EP1650310A1 Recombinant avian adenovirus vector |
| 04/26/2006 | EP1650266A1 Product of coprecipitation of sparingly soluble substance and water-soluble polymer and process for producing the same |
| 04/26/2006 | EP1650225A1 Hetero type pentamer recombinant vaccine |
| 04/26/2006 | EP1649881A1 Drug releasing elastic band and method |
| 04/26/2006 | EP1649872A1 Sheet for guiding regeneration of mesenchymal tissue and production method thereof |
| 04/26/2006 | EP1649867A1 Stable thrombin composition |
| 04/26/2006 | EP1649864A1 Periodontal disease therapeutic and/or preventive composition |
| 04/26/2006 | EP1649860A1 Pharmaceutical composition for ophthalmic use |
| 04/26/2006 | EP1649858A1 Method of preparing an aqueous meloxicam solution and aqueous solution thus produced |
| 04/26/2006 | EP1649854A1 Processed fat composition for preventing/ameliorating lifestyle-related diseases |
| 04/26/2006 | EP1649853A2 Microtubule stabilizing agents for treating atherosclerosis or restenosis |
| 04/26/2006 | EP1649851A2 Pregelatinized starch in a controlled release formulation |
| 04/26/2006 | EP1649850A1 Preparation of biodegradable microparticles containing a biologically active agent |
| 04/26/2006 | EP1649849A2 Compositions for the treatment of Parkinson's disease containing a CB1 receptor antagonist and a product that activates the dopaminergic neurotransmission in the brain. |
| 04/26/2006 | EP1649761A1 Composition for the treatment of chronic venous insufficiencies comprising an extract of red vine leaves |
| 04/26/2006 | EP1649758A1 Masticatable capsule and process for producing the same |
| 04/26/2006 | EP1649263A2 Composite nanoparticles |
| 04/26/2006 | EP1649037A2 Immobilization of oligonucleotides and proteins in sugar-containing hydrogels |
| 04/26/2006 | EP1648988A1 Process for the purification of non-ionic solvents for stabilized injectable pharmaceutical formulations |
| 04/26/2006 | EP1648827A2 Calcium carbonate granulation |
| 04/26/2006 | EP1648824A1 Amorphous silica particles having high absorbing capabilities and high structural characteristics |
| 04/26/2006 | EP1648707A2 Application of a bioactive agent to a delivery substrate |
| 04/26/2006 | EP1648706A1 Dot-topography control of dissolution rate of bioactive agents |
| 04/26/2006 | EP1648551A1 Method and device for improving the permeability of the human skin |
| 04/26/2006 | EP1648527A2 Stabilization and ionic triggering of nitric oxide release |
| 04/26/2006 | EP1648519A2 Lipid encapsulated interfering rna |
| 04/26/2006 | EP1648517A1 Self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids |
| 04/26/2006 | EP1648515A1 Chlorthalidone combinations |
| 04/26/2006 | EP1648497A2 Compositions and methods for selective dissolution of nascent intravascular blood clots |
| 04/26/2006 | EP1648496A1 Method for stabilizing a cryoprecipitate of plasmatic proteins for being subjected to a viral inactivation thermal treatment |
| 04/26/2006 | EP1648491A1 Use of xmp-629 for the treatment of acne |
| 04/26/2006 | EP1648485A2 Formulation for a protein pharmaceutical without added human serum albumin (hsa) |
| 04/26/2006 | EP1648473A1 Single dose fast dissolving azithromycin |
| 04/26/2006 | EP1648472A2 Stable oral compositions of azithromycin monohydrate |
| 04/26/2006 | EP1648471A2 Methods for the treatment of male and female sexual dysfunction |
| 04/26/2006 | EP1648467A1 Process for preparing particles containing an antiviral |
| 04/26/2006 | EP1648454A1 Cci-779 lyophilized formulations |
| 04/26/2006 | EP1648451A2 Fluconazole capsules with improved release |
| 04/26/2006 | EP1648440A1 Semi-solid formulations for the oral administration of taxoids |